Aeolus Pharmaceuticals

OverviewSuggest Edit

Aeolus is developing a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Aeolus is developing its compound, AEOL-10150, as a treatment for the lung effects of Acute Radiation Syndrome (“Lung-ARS”).

StateClosed
TypePublic
Founded1994
HQMission Viejo, US
Websiteaolsrx.com

Locations

Aeolus Pharmaceuticals is headquartered in
Mission Viejo, United States

Location Map

Latest Updates

Employees (est.) (Jun 2017)4
Revenue (FY, 2016)$2.1 M(-33%)

Aeolus Pharmaceuticals Office Locations

Aeolus Pharmaceuticals has an office in Mission Viejo
Mission Viejo, US (HQ)
150 26361 Crown Valley Pkwy
Show all (1)

Aeolus Pharmaceuticals Financials and Metrics

Aeolus Pharmaceuticals Revenue

Aeolus Pharmaceuticals's revenue was reported to be $2.08 m in FY, 2016 which is a 33.3% decrease from the previous period.
USD

Revenue (Q3, 2017)

13.0k

Net income (Q3, 2017)

(949.0k)

EBIT (Q3, 2017)

(949.0k)

Cash (30-Jun-2017)

403.0k
Annual
USDFY, 2013FY, 2015FY, 2016

Revenue

3.9m3.1m2.1m

Revenue growth, %

(33%)

General and administrative expense

3.3m2.2m2.5m

R&D expense

3.4m3.5m2.9m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

1.4m5.0m925.0k1.2m63.0k305.0k660.0k83.0k129.0k13.0k

General and administrative expense

702.0k577.0k650.0k604.0k578.0k561.0k628.0k681.0k570.0k537.0k

R&D expense

1.2m2.8m973.0k1.3m269.0k492.0k904.0k489.0k594.0k425.0k

Operating expense total

1.9m3.4m1.6m1.9m847.0k1.1m1.5m1.2m1.2m962.0k
Annual
USDFY, 2013FY, 2015FY, 2016

Cash

869.0k94.0k3.2m

Accounts Receivable

370.0k1.6m750.0k

Current Assets

1.9m1.7m4.1m

Total Assets

2.0m1.8m4.2m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

520.0k1.3m447.0k248.0k416.0k5.4m3.8m1.9m981.0k403.0k

Accounts Receivable

1.8m2.7m1.8m1.8m656.0k871.0k742.0k544.0k603.0k313.0k

Current Assets

3.9m4.9m2.7m2.2m1.2m6.4m4.8m2.6m1.7m762.0k

Total Assets

3.9m4.9m2.8m2.2m1.2m6.4m4.9m2.6m1.8m794.0k
Annual
USDFY, 2013FY, 2015FY, 2016

Net Income

(3.2m)(2.6m)(3.6m)

Depreciation and Amortization

6.0k

Accounts Payable

(1.6m)46.0k(626.0k)

Cash From Operating Activities

(3.0m)(2.4m)(3.1m)
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(1.1m)1.6m(698.0k)(712.0k)(2.2m)(1.0m)(872.0k)(1.1m)(1.0m)(3.1m)

Accounts Payable

1.8m2.4m1.3m1.8m(87.0k)(802.0k)661.0k(458.0k)638.0k(385.0k)

Cash From Operating Activities

(349.0k)(1.1m)(820.0k)(1.3m)(2.8m)

Cash From Financing Activities

20.0k6.2m
USDY, 2017

Revenue/Employee

3.3k

Financial Leverage

3.8 x
Show all financial metrics

Aeolus Pharmaceuticals Frequently Asked Questions

  • When was Aeolus Pharmaceuticals founded?

    Aeolus Pharmaceuticals was founded in 1994.

  • How many employees does Aeolus Pharmaceuticals have?

    Aeolus Pharmaceuticals has 4 employees.

  • What is Aeolus Pharmaceuticals revenue?

    Latest Aeolus Pharmaceuticals annual revenue is $2.1 m.

  • What is Aeolus Pharmaceuticals revenue per employee?

    Latest Aeolus Pharmaceuticals revenue per employee is $519 k.

  • Who are Aeolus Pharmaceuticals competitors?

    Competitors of Aeolus Pharmaceuticals include Alimera Sciences, Humanigen and AcelRx Pharmaceuticals.

  • Where is Aeolus Pharmaceuticals headquarters?

    Aeolus Pharmaceuticals headquarters is located at 150 26361 Crown Valley Pkwy, Mission Viejo.

  • Where are Aeolus Pharmaceuticals offices?

    Aeolus Pharmaceuticals has an office in Mission Viejo.

  • How many offices does Aeolus Pharmaceuticals have?

    Aeolus Pharmaceuticals has 1 office.